Oops,
for an optimal navigation,
please enable your Scripts
Skip to main content
nl
fr
en
de
Other official information and services:
www.belgium.be
Your medicine and health products
About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal
Home
Human use
Veterinary use
Information for the public
Information for professionals
Home
Human use
Medicines
Medicines
Medicines
COVID-19
Research and development
Vaccines
Scientific-technical advice
Introduction
Procedures
Regulation
Fees
FAQ's
Statistics
National Innovation Office
Meeting with FAMHP experts
Innovation activities
Specific support to SMEs and academics
Presentations, workshops & events
Contact
Research & Development
Clinical trials
Fees
Vigilance
Ethic committee
compassionate use - medical need
Marketing Authorisation procedures
Procedures
Procedures after the first marketing autorisation
Falsified Medicines Directive 2011/62/EU
CTD
eSubmission
Pharmacovigilance
Reglementation
Notification
Data collection, evaluation and measures
VIG-NEWS
DHPC's - Direct Healtcare Professional Communications
Info ICSRs - MAH & sponsors
Inspections - QPPV
Production
Good Manufacturing Practice
Qualified person
FAQ's
Distribution & Delivery
Good Distribution Practices
Brokers
Marketing/ Unavailability
Sunset clause
Full-line wholesalers
Pharmacy for the public
Hospital pharmacy
Therapeutic Magistral Form
Fiscal importation of medicinal products from third countries: clarification of the provisions
Autorisations - certificates
Authorisation RD 14/12/2006
Authorisation RD 30/06/2004
Request for certificates, seen and certified copy
Templates certificates
Certificates prices
Declarations - Registrations
Medicines for export
Manufacturing activity as a sub-contractor
API - fabrication - importation - distribution
Proper use of medicine
Information for a proper use
Risk Management Programme
INN prescription
Advertising-premiums-advantages-samples
Responsible for information
Last updated on 17/02/2016
